Contents

Current Drug Therapy, Volume 5 - Number 2

Incretin-Based Therapies in Patients with Type 2 Diabetes

, 5(2): 75 - 85

Jeffrey S. Freeman and DO


DOI: 10.2174/157488510791065094




New Prospects for the Drug Treatment of Generalized Anxiety Disorder — A Systematic Review

, 5(2): 86 - 94

Paul Glue, Alistair Loan and Chris Gale


DOI: 10.2174/157488510791065120




Novel Vaginal Drug Delivery Systems: A Review

, 5(2): 95 - 104

Umme Hani, R. Sudeendra Bhat, Ritesh Sisodiya and Hosakote Gurumallappa Shivakumar


DOI: 10.2174/157488510791065067




Brain Drug Delivery System: An Overview

, 5(2): 105 - 110

Pushpanjali C. Ligade, Kisan R. Jadhav and Vilasrao J. Kadam


DOI: 10.2174/157488510791065085




Appraisal of Saxagliptin as Treatment of Type 2 Diabetes

, 5(2): 111 - 117

Nasser Mikhail and Dennis Cope


DOI: 10.2174/157488510791065049




Trends in the Treatment of Hepatocellular Carcinoma

, 5(2): 118 - 121

Janine M. Davies and Bert H. O'Neil


DOI: 10.2174/157488510791065111




A Guide to Treatment of Sarcoidosis

, 5(2): 122 - 131

Ilias C. Papanikolaou, Hidenobu Shigemitsu and Om P. Sharma


DOI: 10.2174/157488510791065102




Interferon Therapy for Malignant Solid Tumors

, 5(2): 132 - 138

Katherine E. Warren and Howard A. Young


DOI: 10.2174/157488510791065058




Reasons for Physicians Choice of Medication in Medication-Naive Patients with ADHD: Baseline Data from the COMPLY Observational Study

, 5(2): 139 - 150

Peter M. Wehmeier, Alexander Schacht, Ralf W. Dittmann and Tobias Banaschewski


DOI: 10.2174/157488510791065076




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science